Upsher-Smith Laboratories introduces new formulation of PreNexa Rx prenatal vitamins

Upsher-Smith Laboratories, Inc. is pleased to announce the introduction of a new formulation of PreNexa® Rx prenatal vitamins.  The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265 mg to 300 mg and increased vitamin D3, from 170 IU to 400 IU.

DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development. Vitamin D is an essential vitamin for mom's and baby's skeletal health.

"PreNexa® is the fastest growing single-capsule prenatal vitamin with plant-based DHA on the market.  This new formulation reflects the increasing body of evidence pointing to the important role DHA and vitamin D play in pregnancy, lactation and infancy," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc.  

The NDC number for the new formulation of PreNexa® is 0245-0177-30.  Key product features remain the same, including: the bottle configuration, amount per bottle (30 gel capsules), look of the gel capsule, and regimen of one pill once daily.